Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)

NCT01081496 · clinicaltrials.gov ↗
COMPLETED
Status
1000
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca